Prittle Prattle Pr

Author: admin

  • Mankind Pharma Reports ₹3,570 Cr Revenue in Q1FY26, Grows 24.5% YoY with 23.8% EBITDA Margin

    India’s fourth-largest pharma company posts strong domestic growth, 81.1% export surge, and 15% rise in consumer healthcare revenue led by flagship brands and new launches

     Mankind Pharma Limited (BSE: 543904 | NSE: MANKIND), India’s fourth-largest pharmaceutical company by revenue, has reported consolidated revenue of ₹3,570 crore for the quarter ended June 30, 2025, marking a year-on-year growth of 24.5 percent. The company’s EBITDA stood at ₹850 crore, translating into a margin of 23.8 percent, an improvement of 20 basis points over the same quarter last year.
    Mankind’s strong performance this quarter was led by its domestic formulation business, which contributed ₹3,101 crore in revenue, up 18.9 percent year-on-year. Its export segment also delivered a significant boost, growing by 81.1 percent to ₹469 crore, driven primarily by the consolidation of BSV and incremental gains in its base business.
    The company’s consumer healthcare vertical reported ₹237 crore in revenue, representing a 15 percent increase compared to the corresponding quarter last year. This growth was supported by robust performance from its leading over-the-counter brands such as Gas-O-Fast, Manforce Condoms, HealthOk, and Preganews, which registered secondary sales growth of 36%, 18%, 15%, and 12% respectively.

    Within the domestic pharmaceutical business, Mankind continued to outperform the Indian Pharmaceutical Market (IPM). Secondary sales grew by 9.2 percent versus the IPM’s 8.6 percent, with respiratory and anti-infective therapies delivering 17.8 percent and 9.1 percent growth, respectively. Chronic therapies also contributed to the outperformance, with cardiac and anti-diabetic portfolios expanding at 1.5x and 1.6x the IPM growth rate.
    The company’s market share rose to 4.9 percent as of June 2025, up from 4.8 percent in March, consolidating its leadership in physician prescriptions. Mankind has maintained the number one position in India by prescription share for eight consecutive years, currently holding a 15.4 percent share, as per IQVIA June 2025 data.

    Notably, the company also reported expansion in its e-commerce and modern trade (MT) channels. These accounted for 11 percent of consumer healthcare revenue in Q1FY26, compared to 9 percent in the same period last year, supported by approximately 50 percent YoY growth in digital and organised retail distribution.
    On the product innovation front, Mankind Pharma continues to scale its consumer health portfolio with new launches such as Epic ThinX (premium unflavored condoms), Nimulid in pain management, and OvaNews (ovulation detection kit), positioning itself to capture growth across lifestyle and wellness categories.
    Mankind’s financial data reflects both volume and portfolio expansion. Gross margins for the quarter stood at 70.5 percent, and PAT margin was 12.5 percent. Profit after tax came in at ₹445 crore, while diluted earnings per share (EPS) stood at ₹10.6.

    The company’s Q1FY26 performance was also notable in the context of sequential momentum. Compared to Q4FY25, revenue rose 15.9 percent, while EBITDA was up 24 percent. This suggests operating leverage coming into play, with continued margin discipline and revenue scale.
    The earnings call for Q1FY26 is scheduled on 1st August 2025 at 12:00 PM IST. Investors can access the call through the company’s designated universal access numbers or via Diamond Pass registration.
    As Mankind Pharma continues to deepen its footprint across therapeutic and consumer categories, its balanced growth across prescription-led, OTC, and global markets underscores its dual focus on domestic leadership and international scale.

    At Prittle Prattle News, we honor your dedication and inventiveness led by showcasing you in a positive light. Under the direction of Editor-in-Chief Smruti Bhalerao, our platform is committed to disseminating powerful narratives that raise awareness and motivate change. For more important stories, follow us on LinkedIn, Instagram, and YouTube.

  • Asian Energy Services Secures ₹865 Crore Contract from Vedanta for Operations & Maintenance

    AESL wins integrated upstream services mandate worth ₹865 Cr over 57 months, driving enhanced uptime, process innovation, and job creation

     Asian Energy Services Limited (AESL), a key player in India’s energy and mining services ecosystem, has secured a ₹865 crore integrated service contract from Vedanta Limited. The engagement spans 57 months and is structured to cover comprehensive field development and upstream infrastructure management for Vedanta’s operational blocks.
    This mandate reinforces AESL’s strategic position in India’s upstream oil and gas sector, a segment now witnessing a renewed push towards brownfield optimization and integrated field services. As the Indian government pursues its target of reducing crude oil imports by 10%, domestic producers like Vedanta are intensifying operational efficiency and maximizing production through high-impact field partnerships.

    The scope of AESL’s contract encompasses upstream planning, development execution, skilled manpower deployment, 24×7 operations support, predictive maintenance, and performance optimization. It also requires AESL to deliver on regulatory compliance and production uptime targets, responsibilities that speak to its growing reputation in mission-critical energy projects.
    Commenting on the win, Dr. Kapil Garg, Managing Director, Asian Energy Services Limited said, “We are honoured to receive this integrated service mandate from Vedanta, one of our most valued clients. This repeat engagement reflects the trust we’ve built through operational delivery and our emphasis on safety, quality, and uptime excellence. Integrated operations and maintenance is a key growth driver for AESL, and we remain committed to delivering consistent performance across India’s energy landscape.”

    The ₹865 crore contract is expected to significantly strengthen AESL’s order book visibility and secure forward revenue for nearly five financial years. It also positions the company more firmly in the annuity-based project segment, a focus area for AESL as it scales in complexity and capital efficiency.
    Execution will be centered in Rajasthan, where Vedanta has a strong upstream footprint. The project is anticipated to generate both direct and indirect employment in core operations, logistics, and project management. Additional support functions across other states are expected to benefit through service-linked employment, local vendor participation, and logistics engagement.
    This deal is particularly strategic as India’s upstream operators shift from piecemeal contracts to full-service partners capable of managing entire value chains, from seismic data to facility operations. AESL’s track record in onshore and offshore services, paired with its ability to scale across project scopes, made it a natural fit for Vedanta’s latest tender.

    AESL’s integrated offerings span 2D and 3D seismic acquisition, operations and maintenance of oil and gas production facilities, material handling infrastructure, and production enhancement services. Since its acquisition by Oilmax Energy Private Limited (OEPL), AESL has evolved from a seismic services provider to a full-stack energy partner. This contract, one of its largest in recent quarters, is a natural continuation of that growth strategy.
    The company’s existing work with Vedanta spans multiple years, and this contract builds on that operational relationship. The announcement also comes at a time when private oil and gas players in India are investing heavily in automation, remote field operations, and predictive maintenance, areas where AESL has built specific project capabilities.
    In addition to its upstream focus, AESL continues to expand its mining verticals, working on large material handling plant installations and rapid loading systems. However, this Vedanta deal places the spotlight squarely back on upstream services, where duration-linked annuity contracts offer both visibility and scalability.
    AESL’s commitment to safe operations and infrastructure reliability remains core to its service promise. With the Vedanta project now added to its portfolio, the company is expected to consolidate its position as one of India’s few integrated service specialists with capabilities across both energy and infrastructure.
    At Prittle Prattle News, we honor your dedication and inventiveness led by showcasing you in a positive light. Under the direction of Editor-in-Chief Smruti Bhalerao, our platform is committed to disseminating powerful narratives that raise awareness and motivate change. For more important stories, follow us on LinkedIn, Instagram, and YouTube.

  • SMT Limited Moves Toward IPO With ₹1,024.88 Cr in FY25 Revenue and CE-Backed Innovations

    Founded by Dhirajlal Kotadia, the medical device firm leads India’s DES market and expands across 76 countries with patented tech and strategic acquisitions

    Sahajanand Medical Technologies Limited (SMT), a company anchored in precision-driven cardiovascular care, has filed its Draft Red Herring Prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) to initiate its public listing on the BSE and NSE. The IPO is structured entirely as an offer for sale, comprising up to 27,644,231 equity shares of face value ₹1 each, offered by its promoters and institutional investors.
    Founded in 2001 by Dhirajlal Kotadia, SMT has steadily scaled its reputation in the Class III and Class C/D medical devices space, developing proprietary solutions in both vascular and structural heart intervention. As of March 31, 2025, the company has commercial presence in 76 countries and operates through a mix of direct subsidiaries and distributor-led models, particularly in Europe, Southeast Asia, and Latin America.

    The offer for sale includes equity shares from major stakeholders including Shree Hari Trust, Dhirajkumar Savjibhai Vasoya, Samara Capital Markets Holding Limited, Kotak Pre-IPO Opportunities Fund, and NHPEA Sparkle Holding B.V. Other notable shareholders include Plutus Wealth Management LLP and individual investor Ashish Kacholia.
    The IPO structure reserves a discount-linked subscription for eligible employees under the employee reservation portion, while the broader allocation follows the book-building format: not more than 50% to qualified institutional buyers (QIBs), a minimum of 15% to non-institutional investors, and at least 35% to retail investors.
    SMT’s product lineup spans coronary stents, coronary balloons, renal stents, trans-catheter aortic valves, occluders, and peripheral drug-coated balloons. Its flagship innovation, Supraflex Cruz, is a drug-eluting stent (DES) built with a biodegradable polymer and enhanced deliverability through SMT’s proprietary LDZ link. SMT is also credited as the first company globally to secure a CE certification for a biodegradable polymer DES.

    According to data from the F&S Report included in the DRHP, SMT holds a 25% market share in India’s DES segment as of CY2025, leading by volume. It is also ranked among the top five DES suppliers by volume in Germany, Spain, Poland, and Brazil. The company has also secured top-five placement in the occluders segment in India, Thailand, and South Korea.
    SMT has two R&D centers, one in India and another in Thailand, supporting a portfolio of 102 granted patents and 71 active patent applications worldwide, along with five design registrations in India. Following its acquisition of Thailand-based Vascular Innovations, SMT developed the Aortic Valve Delivery Catheter (AVDC) system for its Hydra TAVI product, further expanding its innovation capabilities.
    On the financial front, SMT reported revenue from operations of ₹1,024.88 crore in Fiscal 2025, a 13.67% increase from ₹901.60 crore in Fiscal 2024. This growth was attributed largely to strong device sales across Europe and the rest of the world, with particular momentum in the structural heart vertical. The company also posted a profit of ₹25.15 crore in FY25, a reversal from a loss of ₹7.35 crore in the previous fiscal year.

    Domestically, SMT operates through a hybrid distribution model, supplying devices to hospitals including Narayana Hrudayalaya Limited. In Europe, the company runs direct operations in Germany, Spain, France, and the United Kingdom. It has transitioned from distributor-led to direct models in Spain, following the acquisition of Imex, and now operates a hybrid model in Brazil through its acquisition of Zarek.
    SMT’s clinical credibility is reinforced by 72 clinical studies, of which 60 have been completed and 12 are ongoing. These trials span diverse geographies and patient populations, focusing on core offerings such as Supraflex Cruz, Hydra, Pipit, and Cocoon.

    The IPO is being managed by Motilal Oswal Investment Advisors Limited, Avendus Capital Private Limited, HSBC Securities and Capital Markets (India) Private Limited, and Nuvama Wealth Management Limited. MUFG Intime India Private Limited is acting as the registrar to the issue.
    SMT’s public issue positions the company to consolidate its leadership in the cardiovascular device space, deepen its reach across regulated international markets, and maintain its focus on research-led manufacturing. With India now crossing 50% non-fossil installed power capacity and medical infrastructure seeing increased capital flow, SMT’s timing aligns with broader themes of precision healthcare, regulatory maturity, and Make in India–backed innovation.
    At Prittle Prattle News, we honor your dedication and inventiveness led by showcasing you in a positive light. Under the direction of Editor-in-Chief Smruti Bhalerao, our platform is committed to disseminating powerful narratives that raise awareness and motivate change. For more important stories, follow us on LinkedIn, Instagram, and YouTube.

  • From Hospital Wards to FRAC Labs: Dietetics that Combine Medical Nutrition and Food Science

    By Pranjal Kumat, Dietitian

    In a country facing a rising burden of both undernutrition and metabolic disease, the role of dietetics is expanding beyond calorie counts and lifestyle advice. Nutrition today demands a practice that can engage clinical complexity, fitness-driven goals, and regulatory standards in food science. It was through three distinct, grounded experiences that I learned how to view this field as more than a discipline, it became a responsibility rooted in evidence, relevance, and adaptability.
    My first year of hands-on work unfolded inside a fitness club. Here, I supported clients in their pursuit of composition goals, endurance performance, and structured weight management. Each nutrition plan was tailored to fit a lifestyle, not a formula. I learned quickly that people don’t eat nutrients, they eat habits. The plans I built accounted for macronutrient precision, meal timing, and adherence strategies. The feedback loop was clear: body transformation outcomes came from behavioral understanding as much as dietary logic.

    Stepping out of this setting and into the wards of Mahatma Gandhi Medical College and Hospital revealed a different side of the nutrition spectrum. During my six-month internship in the clinical dietetics department, I assisted with patient care under the guidance of doctors, therapeutic dietitians, and clinical staff. The focus shifted to patients navigating chronic illnesses, diabetes, renal disease, cardiovascular complications, and gastrointestinal disorders. Medical nutrition therapy wasn’t just about numbers; it was about healing. It involved understanding pathophysiology, metabolic stress, and the emotional landscape of those managing illness. The transition from wellness-based planning to hospital-grade intervention taught me that food is not just fuel, it is treatment, recovery, and prognosis management.

    The third phase of my training took place in a laboratory, not a kitchen or clinic. I completed a 45-day internship at FICCI FRAC Labs, where food analysis, safety protocols, and regulatory frameworks formed the core curriculum. Here, I was trained in nutritional labeling, food composition testing, and safety compliance under ISO and NABL standards. This phase taught me how ingredients translate to data. From batch samples to shelf-life estimation, I learned the critical link between public trust and food system transparency.
    These three stages, applied nutrition in fitness, clinical care in hospitals, and regulatory insight in labs, shaped the dietetic philosophy I now carry forward. Nutrition is not isolated to one patient, one meal, or one setting. It spans intent, risk, and scale.

    India’s evolving health landscape confirms the need for this approach. According to the Indian Council of Medical Research, the country is witnessing a sharp rise in metabolic obesity even among individuals with normal body mass. A growing segment of the population now lives with undiagnosed diabetes, micronutrient deficiencies, or chronic lifestyle-driven disease. Public health systems are catching up, but dietetics must lead, not follow.
    I do not believe in generalised advice. Every consultation, plan, or intervention must carry context, clinical, personal, and even environmental. It is not enough to know what works in theory. We need to understand what works for whom, in what setting, and why.

    My experiences across these three settings did more than expand my technical skills. They allowed me to see dietetics as an integrative system, one that connects health outcomes with food literacy, regulatory accuracy, and the realities of lived behavior. Whether working with a patient in recovery, an athlete aiming to enhance performance, or a brand committed to clean labels, my approach remains consistent: evidence over assumption, clarity over complication.
    As I continue on this professional path, I remain committed to pushing for nutrition that works, not in concept, but in context.
    At Prittle Prattle News, we honor your dedication and inventiveness led by showcasing you in a positive light. Under the direction of Editor-in-Chief Smruti Bhalerao, our platform is committed to disseminating powerful narratives that raise awareness and motivate change. For more important stories, follow us on LinkedIn, Instagram, and YouTube.

  • Syngene Q1FY26: Revenue up 11%, PAT surges 59% as biologics and peptides scale

    Strong start to FY26 with ₹875 Cr revenue; USFDA clearance, 20+ audits, and peptide lab expansion underline quality-first strategy

    Bengaluru, 23 July 2025 ,  Syngene International Ltd. began FY26 with solid performance in the first quarter, reporting an 11% year-on-year increase in revenue from operations to ₹875 crore and a 59% surge in profit after tax (PAT) to ₹87 crore. The company’s reported EBITDA rose 19% to ₹224 crore, with margins improving to 25%.
    Operational Growth: Research Services and Biologics Power Q1 Momentum
    The strong financial delivery was driven by continued conversion of pilot programs into long-term contracts within the Research Services business and progress in biologics manufacturing. Syngene commenced operations at its new Unit III facility in Bengaluru and is advancing preparations to launch operations at its Bayview site in the United States later in the year.

    Peter Bains, Managing Director and CEO of Syngene International Ltd., stated:
    “We are pleased with the growth performance in the first quarter, which is aligned with our expectations. Continued conversion of pilot programs into longer-term contracts within our Research Services business was the main driver underpinning this momentum. We have also made progress in scaling biologics and expanding scientific platform capabilities with a new peptide lab.”
    Quality Milestones and Global Compliance
    In Q1FY26, Syngene successfully completed a USFDA Good Clinical Practices (GCP) inspection of its Human Pharmacology Unit with no observations. Its Biologics facility at Biocon Park received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) outcome.
    The company also concluded over 20 client and regulatory audits in the quarter, reinforcing its commitment to global compliance and operational transparency.

    Scientific Expansion: Peptides & Platform Synergies
    Syngene inaugurated a state-of-the-art dedicated peptide laboratory, enhancing its portfolio alongside monoclonal antibodies, Antibody-Drug Conjugates (ADCs), oligonucleotides, and PROTACs. Peptides are among the fastest-growing therapeutic modalities and strengthen Syngene’s integrated capabilities across development and manufacturing.
    Deepak Jain, Chief Financial Officer, commented:
    “This quarter’s revenue growth of 11% and improvement in EBITDA margins were driven by both topline momentum and cost optimization. We continue to maintain a robust balance sheet and will invest in technology to strengthen client offerings while staying focused on our annual guidance.”
    Recognition for Sustainability
    Syngene was named one of the World’s Most Sustainable Companies 2025 by TIME magazine and Statista. It ranked #1 in India’s pharma and biotech sector and within the top 20 globally in life sciences, chosen from a pool of over 5,700 organizations. This highlights Syngene’s strategic alignment with environmental stewardship and global ESG leadership.

    Upcoming Investor Call
    Syngene will host its Q1FY26 earnings call on July 24, 2025, at 12:15 PM IST, where senior management will discuss performance and outlook. Details for dial-in and webcast access are available on the company’s official website.
    About Syngene International Ltd.
    Syngene International Ltd. (BSE: 539268, NSE: SYNGENE) is a globally integrated research, development, and manufacturing services provider for pharmaceutical, biotech, nutrition, animal health, and specialty chemicals. With over 5,600 scientists and 2.5 million+ sq. ft. of infrastructure, Syngene supports 400+ clients including global leaders such as BMS, GSK, Zoetis, and Merck KGaA

    At Prittle Prattle News, we honor your dedication and inventiveness led by showcasing you in a positive light. Under the direction of Editor-in-Chief Smruti Bhalerao, our platform is committed to disseminating powerful narratives that raise awareness and motivate change. For more important stories, follow us on LinkedIn, Instagram, and YouTube.

  • CMS Info Systems Q1FY26: Revenue up 5%, PAT up 3%, Vision AI play deepens

    Company secures ₹500 Cr in new orders, scales HAWKAI brand with Securens acquisition

    CMS Info Systems Limited, India’s largest business services firm in cash logistics and technology-led managed services, reported a stable Q1FY26 performance, with consolidated revenue rising 5% year-on-year to ₹627 crore and profit after tax (PAT) up 3% to ₹93.6 crore.
    The company continues to deepen its technology-led transformation with a binding agreement to acquire Securens Systems Private Limited, an AIoT remote monitoring pioneer, for a reported ₹80 crore. This move significantly strengthens CMS’s Vision AI vertical under its flagship HAWKAI brand, aiming to more than double its competitive lead in the surveillance and analytics segment.
    Segmental Performance: Stability in Cash Logistics, Investment in Managed Services

    • Cash Logistics revenue stood at ₹417 crore (YoY growth: 8%) with EBIT at ₹100 crore (YoY growth: 1%)
    • Managed Services & Technology Solutions, which includes Cards Services, delivered ₹258 crore in revenue (YoY growth: 8%) but saw EBIT decline by 11% to ₹36 crore

    Key Q1FY26 Highlights

    • ₹500 crore worth of new orders secured across segments
    • 153,000+ business touch points in the Cash Logistics vertical, a 9% YoY increase
    • Won ALGO MVS contract for ICICI Bank’s ATM software solutions
    • Strategic acquisition of Securens to deepen Vision AI and predictive analytics capabilities

    Rajiv Kaul, Executive Vice Chairman and CEO of CMS Info Systems, stated:
    “We grew topline by 5% and PAT by 3% in a seasonally weak quarter amid subdued consumption trends. We continue to focus on executing our order book while maintaining a stable business profile. With the Securens acquisition, our HAWKAI brand will scale to a market-leading position, more than 2X of its closest competitor.”

    Vision AI Expansion: From Cash to Code
    Securens Systems, ranked #4 in India’s AIoT RMS sector, brings advanced capabilities in intelligent surveillance, predictive compliance, and analytics-led security services. This acquisition positions CMS to serve clients across banking, retail, and e-commerce with a full-stack Vision AI platform.
    The integration of Securens’ stack into CMS’s ecosystem will allow cross-leveraging of AIoT surveillance with existing logistics infrastructure, accelerating HAWKAI’s reach and enabling real-time, tech-enabled compliance.
    Investor & Analyst Relations
    CMS Info Systems will host its earnings call on July 24, 2025, at 4:00 PM IST, with access via universal dial-in numbers and full materials to be published on the company’s official investor portal.

    About CMS Info Systems
    CMS Info Systems Ltd is India’s leading business services company providing logistics and technology solutions to banks, financial institutions, retail, and e-commerce sectors. Listed on the BSE and NSE (Ticker: CMSINFO), CMS operates across three verticals: Cash Logistics, Managed Services, and Technology Solutions. The company maintains a digital presence on LinkedIn, Instagram, Twitter, and Facebook under the handle CMS Info Systems.
    At Prittle Prattle News, we honor your dedication and inventiveness led by showcasing you in a positive light. Under the direction of Editor-in-Chief Smruti Bhalerao, our platform is committed to disseminating powerful narratives that raise awareness and motivate change. For more important stories, follow us on LinkedIn, Instagram, and YouTube.

  • Paytm Turns Profitable With ₹123 Cr PAT, Revenue Up 28% in Q1 FY26

    Merchant subscriptions hit 1.3 Cr; financial services revenue doubles; EBITDA at ₹72 Cr

     Paytm (One 97 Communications Limited) has reported a consolidated profit after tax (PAT) of ₹123 crore for the first quarter of FY26, marking a profitable quarter across all key financial metrics. Operating revenue surged 28% year-on-year to ₹1,918 crore, driven by growth in merchant subscriptions and distribution of financial services. The company posted an EBITDA of ₹72 crore and a contribution margin of 60%, underscoring the strength of its AI-led cost discipline and monetization strategy.
    Net payment revenue rose 38% YoY to ₹529 crore, bolstered by an increase in high-quality subscription merchants and better payment processing margins. Financial services revenue doubled to ₹561 crore, attributed to strong momentum in merchant loans, trail revenue from the Default Loss Guarantee (DLG) portfolio, and improved loan recovery performance.

    Merchant subscriptions reached an all-time high of 1.30 crore as of June 2025. Paytm continues to enhance operating efficiency through reduced capital expenditure on devices and improved sales team productivity. With AI embedded across its operations, the company has successfully optimized its technology stack to serve MSMEs and large enterprises alike.
    With a cash balance of ₹12,872 crore as of June 30, Paytm maintains capital flexibility to accelerate innovation in AI-first infrastructure, merchant services, and financial product expansion. The platform is India’s only full-stack, AI-powered omni-channel payments ecosystem, offering integrated hardware, software, and services.

    Paytm anticipates that more than 10 crore merchants will adopt digital payments in the near term, with 40-50% likely to require subscription-based business services—a segment where Paytm holds market leadership.
    As one of India’s earliest AI adopters in fintech, the company has integrated AI into merchant onboarding, transaction analytics, risk scoring, and customer support. This has helped unlock operating leverage, control direct expenses, and scale without proportionate cost increase.

    About Paytm
    Paytm is India’s leading mobile payments and financial services distribution company. As a pioneer of mobile QR payments in India, the company builds technologies that empower small businesses with seamless payments and commerce. Its mission is to serve half a billion Indians and integrate them into the mainstream economy through digital innovation.
    At Prittle Prattle News, we honor your dedication and inventiveness led by showcasing you in a positive light. Under the direction of Editor-in-Chief Smruti Bhalerao, our platform is committed to disseminating powerful narratives that raise awareness and motivate change. For more important stories, follow us on LinkedIn, Instagram, and YouTube.

  • Rosmerta Wins ₹109.15 Cr Contract for 6 Automated Testing Stations in Maharashtra

    Gondia, Jalgaon, Nandurbar, Ratnagiri, Beed, and Chiplun to get BOOT model ATS under state transport upgrade

    Rosmerta Group has secured a ₹109.15 crore contract to establish six state-of-the-art Automated Testing Stations (ATS) across Maharashtra. The project, awarded under a Build-Own-Operate-Transfer (BOOT) model in partnership with the State Transport Department, will deploy advanced vehicle testing facilities in Gondia, Jalgaon, Nandurbar, Ratnagiri, Beed, and Chiplun over the next five years. The initiative marks a major step forward in Maharashtra’s push for standardized, tech-driven vehicle fitness assessment infrastructure aligned with Chapter XI of the Central Motor Vehicle Rules (CMVR).
    Each ATS will feature fully automated systems capable of evaluating vehicle roadworthiness with enhanced accuracy, transparency, and efficiency. The new centres are expected to significantly reduce manual testing errors, streamline compliance protocols, and bring consistent safety standards to regions that have traditionally lacked modern testing infrastructure.

    Mr. Kartick Nagpal, President of Rosmerta Group, stated, “We are honoured to partner with the State Transport Department of Maharashtra to bring world-class, technology-driven Automated Testing Stations to the state under the BOOT model. These centres will enhance road safety by making vehicle fitness testing more precise, transparent, and accessible, especially in regions where such infrastructure has been limited.”

    The Maharashtra ATS agreement is a key component of Rosmerta’s broader roadmap, which includes a ₹400 crore investment to build 21 ATS across the state. The company’s ongoing pilot and commercial programs, commissioned under the Ministry of Road Transport and Highways (MoRTH), have successfully processed over 500,000 vehicle tests to date.

    Rosmerta Technologies Limited, a pioneer in Indian mobility infrastructure, holds a dominant 50% market share in High-Security Registration Plates (HSRP), making it the second-largest global HSRP manufacturer and India’s largest. The company also leads multiple allied verticals such as Intelligent Transport Management Systems, Automated Driving Testing Tracks, Vehicle Scrapping Facilities, IoT-based Transport Solutions, and Smart Card-based licensing and registration services.
    The company’s Surakshit Safar initiative underscores its ESG-driven mission to improve Indian road safety through integrated, sustainable, and digitally enabled solutions.

    At Prittle Prattle News, we honor your dedication and inventiveness led by showcasing you in a positive light. Under the direction of Editor-in-Chief Smruti Bhalerao, our platform is committed to disseminating powerful narratives that raise awareness and motivate change. For more important stories, follow us on LinkedIn, Instagram, and YouTube.

  • Hindustan Zinc Posts ₹2,234 Cr Profit in Q1 FY26, Beats Estimates

    Q1 sees record mined metal, lowest zinc cost at $1,010/MT, and ₹4,225 Cr dividend declared

    Hindustan Zinc Limited (BSE: 500188, NSE: HINDZINC) reported a profit of ₹2,234 crore for the first quarter of FY26, surpassing analyst estimates. The company achieved its highest-ever Q1 mined metal production at 265 KT and recorded the lowest first-quarter zinc cost of production at US$ 1,010 per MT. The Board also approved an interim dividend of ₹10 per share, amounting to ₹4,225 crore, reinforcing Hindustan Zinc’s track record of delivering value.
    Revenue from operations stood at ₹7,771 crore, down 4% year-on-year, impacted by softer zinc and lead prices and lower volumes. However, gains from higher silver prices, improved by-product realizations, and a stronger US dollar helped cushion the topline. EBITDA for the quarter was ₹3,860 crore, reflecting a decline of 2% YoY, while maintaining an industry-leading EBITDA margin of approximately 50%.

    Profit after tax came in at ₹2,234 crore, down 5% from the previous year, with earnings per share of ₹5.29 and an effective tax rate of approximately 25%.
    Silver remained a significant contributor to the company’s profitability, accounting for 41% of total EBITDA. Silver sales stood at 1,427 MT during the quarter, supported by a 17% year-on-year surge in global silver prices to US$ 33.7/oz.
    Operationally, the company reported its highest-ever first-quarter mined metal production at 265 KT, up 1% YoY. Refined metal production was 250 KT, down 5% YoY, comprising 202 KT of zinc and 48 KT of lead. Sales of refined metal totaled 249 KT. Hindustan Zinc Alloys (HZAPL) reported its highest-ever quarterly production, pushing value-added product share to approximately 24%.

    The zinc cost of production improved by 9% YoY to US$ 1,010 per MT, supported by higher metal grades, greater reliance on domestic coal and renewable energy, and enhanced by-product recovery.
    The company’s balance sheet remained strong with cash and equivalents of ₹9,340 crore as of 30 June 2025. Total borrowings stood at ₹13,524 crore. Hindustan Zinc retains its AAA/Stable credit rating from CRISIL.
    Hindustan Zinc also secured critical mineral assets during the quarter, winning Potash and Halite blocks in Rajasthan and Rare Earth Element (REE) rights in Uttar Pradesh. Sustainability advances included achieving 3.32 times water positivity, increasing renewable energy usage to 19%, and initiating a ₹5 crore conservation project for the 400-hectare Baghdarrah Crocodile Reserve in partnership with the Department of Forest, Udaipur.
    Capital expenditure and strategic projects are on track, including:

    • Commissioning of the 160 KTPA roaster at Debari by mid-Q2 FY26
    • Completion of cellhouse debottlenecking at Dariba and Chanderiya by Q2 FY26
    • 510 KTPA fertilizer plant expected by Q1 FY27
    • Hot acid leaching technology for smelting waste recovery by Q4 FY26
    • Board-approved ₹12,000 crore expansion for a 250 KTPA smelting complex
    CEO Arun Misra stated, “Delivering our highest-ever Q1 mined metal production at the lowest-ever zinc cost reflects our relentless focus on operational efficiency. With strategic investments and secured mineral blocks, Hindustan Zinc is poised to become a multi-metal powerhouse.”
    CFO Sandeep Modi added, “Despite commodity headwinds, our structurally lean cost base and consistent performance enable us to deliver robust returns. The interim dividend and capital plan signal our commitment to long-term value creation.”
    The company also received several recognitions during the quarter:
    • Featured in Time Magazine’s World’s Most Sustainable Companies 2025 list
    • British Safety Council’s “Team of the Year Award”
    • ESG Risk Management Award at CNBC TV-18’s India Risk Management Awards
    • Three accolades at PeopleFirst HR Excellence Awards 2025
    At Prittle Prattle News, we honor your dedication and inventiveness led by showcasing you in a positive light. Under the direction of Editor-in-Chief Smruti Bhalerao, our platform is committed to disseminating powerful narratives that raise awareness and motivate change. For more important stories, follow us on LinkedIn, Instagram, and YouTube.

  • Reverse Mentoring and the Rise of Leaders as Living LLMs: Niranjan Gidwani’s Framework for Modern Leadership

    Senior executives must now train like language models, constantly learning from juniors to lead across tech, culture, and transformation

    In a bold reframing of leadership, certified board director and UAE Superbrands Council member Niranjan Gidwani introduces a new metaphor for modern executive relevance: leaders as living LLMs. In this thought leadership piece, he draws parallels between how generative AI learns and how today’s senior corporate heads must adapt, not by teaching, but by learning from the generation below them. Through reverse mentoring, he argues, executives can constantly train their leadership models by ingesting real-time digital, cultural, and operational perspectives from junior colleagues.

    Traditionally, mentoring in organizations was top-down: seasoned executives shared institutional knowledge with emerging professionals. But that dynamic is evolving. With the rise of digital-first workforces, reverse mentoring has become an institutionalized strategy across global firms. Jack Welch first pioneered it at GE, and companies like Unilever, PwC, and Deloitte now run formal programs pairing senior leaders with younger employees to fast-track executive learning.
    In Gidwani’s view, these programs are not perks, they are survival mechanisms. Just as large language models (LLMs) depend on constant data ingestion to stay relevant, senior leaders must continuously update their worldview through younger, more digitally native counterparts.
    There are three key mechanisms:

    • Absorbing new knowledge: From AI tools to TikTok algorithms, younger employees understand technologies shaping business. Senior leaders gain fluency not through training modules, but through conversation.
    • Challenging legacy assumptions: Junior staff bring disruptive, unfiltered perspectives that force leaders to reevaluate ingrained processes and strategies.
    • Adaptive leadership: Just as LLMs learn from feedback, so must executives iterate their leadership based on real-time input and failure analysis.

    The benefits are multi-tiered. Reverse mentoring boosts digital fluency, drives innovation, and humanizes leadership. At Unilever, junior teams briefed executives on AI-enabled consumer analytics, reshaping campaign strategies. Siemens credited its reverse mentoring with a 20% efficiency bump after junior engineers proposed automation frameworks. IBM leveraged junior feedback to recalibrate executive communication styles, making top brass more relatable and reducing attrition.
    For organizations, the impact is cultural. Reverse mentoring lowers hierarchical walls, fosters psychological safety, and bridges generational divides. When done right, it positions companies as adaptive ecosystems rather than rigid machines.
    To implement this model, Gidwani suggests:

    • Formalize pairings: Match senior leaders with younger mentors based on key learning objectives.
    • Encourage radical candor: Allow honest conversations without fear of reputational fallout.
    • Create structured feedback loops: Measure and refine impact through constant iteration.

    Publicly reward participation: Recognize senior leaders who model learning behavior as brand assets.

    In a world where leadership credibility comes from adaptability, Gidwani argues that senior executives must evolve from being knowledge providers to dynamic learners. Like the best-trained LLMs, their value depends not on what they once knew, but how fast they can update, respond, and iterate.
    He ends with a provocation: Most mentoring programs issue certificates to juniors. Shouldn’t we start acknowledging senior leaders who excel at reverse mentoring as certified Living LLMs?
    The future of leadership may not lie in charisma, but in curiosity.
    At Prittle Prattle News, we honor your dedication and inventiveness led by showcasing you in a positive light. Under the direction of Editor-in-Chief Smruti Bhalerao, our platform is committed to disseminating powerful narratives that raise awareness and motivate change. For more important stories, follow us on LinkedIn, Instagram, and YouTube.